101 related articles for article (PubMed ID: 8701326)
21. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.
Afkarian M; Sedy JR; Yang J; Jacobson NG; Cereb N; Yang SY; Murphy TL; Murphy KM
Nat Immunol; 2002 Jun; 3(6):549-57. PubMed ID: 12006974
[TBL] [Abstract][Full Text] [Related]
22. The protein tyrosine kinase JAK1 complements defects in interferon-alpha/beta and -gamma signal transduction.
Müller M; Briscoe J; Laxton C; Guschin D; Ziemiecki A; Silvennoinen O; Harpur AG; Barbieri G; Witthuhn BA; Schindler C
Nature; 1993 Nov; 366(6451):129-35. PubMed ID: 8232552
[TBL] [Abstract][Full Text] [Related]
23. STATs and gene regulation.
Darnell JE
Science; 1997 Sep; 277(5332):1630-5. PubMed ID: 9287210
[TBL] [Abstract][Full Text] [Related]
24. STAT protein complexes activated by interferon-gamma and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties.
Lamb P; Seidel HM; Haslam J; Milocco L; Kessler LV; Stein RB; Rosen J
Nucleic Acids Res; 1995 Aug; 23(16):3283-9. PubMed ID: 7667105
[TBL] [Abstract][Full Text] [Related]
25. Antiviral response in cells containing Stat1 with heterologous transactivation domains.
Shen Y; Darnell JE
J Virol; 2001 Mar; 75(6):2627-33. PubMed ID: 11222685
[TBL] [Abstract][Full Text] [Related]
26. So many ligands, so few transcription factors: a new paradigm for signaling through the STAT transcription factors.
Subramaniam PS; Torres BA; Johnson HM
Cytokine; 2001 Aug; 15(4):175-87. PubMed ID: 11563878
[No Abstract] [Full Text] [Related]
27. Requirement for MAP kinase (ERK2) activity in interferon alpha- and interferon beta-stimulated gene expression through STAT proteins.
David M; Petricoin E; Benjamin C; Pine R; Weber MJ; Larner AC
Science; 1995 Sep; 269(5231):1721-3. PubMed ID: 7569900
[TBL] [Abstract][Full Text] [Related]
28. Kinase-negative mutants of JAK1 can sustain interferon-gamma-inducible gene expression but not an antiviral state.
Briscoe J; Rogers NC; Witthuhn BA; Watling D; Harpur AG; Wilks AF; Stark GR; Ihle JN; Kerr IM
EMBO J; 1996 Feb; 15(4):799-809. PubMed ID: 8631301
[TBL] [Abstract][Full Text] [Related]
29. Localization of a receptor nonapeptide with a possible role in the binding of the type I interferons.
Eid P; Langer JA; Bailly G; Lejealle R; Guymarho J; Tovey MG
Eur Cytokine Netw; 2000 Dec; 11(4):560-73. PubMed ID: 11125298
[TBL] [Abstract][Full Text] [Related]
30. STATs and cytokine specificity.
Leonard WJ
Nat Med; 1996 Sep; 2(9):968-9. PubMed ID: 8782447
[No Abstract] [Full Text] [Related]
31. Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell.
Ho LJ; Hung LF; Weng CY; Wu WL; Chou P; Lin YL; Chang DM; Tai TY; Lai JH
J Immunol; 2005 Jun; 174(12):8163-72. PubMed ID: 15944325
[TBL] [Abstract][Full Text] [Related]
32. Stat1 combines signals derived from IFN-gamma and LPS receptors during macrophage activation.
Kovarik P; Stoiber D; Novy M; Decker T
EMBO J; 1998 Jul; 17(13):3660-8. PubMed ID: 9649436
[TBL] [Abstract][Full Text] [Related]
33. Dimerization of a chimeric CD4-interferon-alpha receptor reconstitutes the signaling events preceding STAT phosphorylation.
Krishnan K; Yan H; Lim JT; Krolewski JJ
Oncogene; 1996 Jul; 13(1):125-33. PubMed ID: 8700538
[TBL] [Abstract][Full Text] [Related]
34. Affinity of Stat2 for the subunits of the interferon alpha receptor.
Saleh AZ; Nguyen VP; Krolewski JJ
Biochemistry; 2002 Sep; 41(37):11261-8. PubMed ID: 12220192
[TBL] [Abstract][Full Text] [Related]
35. Sendai virus blocks alpha interferon signaling to signal transducers and activators of transcription.
Komatsu T; Takeuchi K; Yokoo J; Tanaka Y; Gotoh B
J Virol; 2000 Mar; 74(5):2477-80. PubMed ID: 10666284
[TBL] [Abstract][Full Text] [Related]
36. Cooperative DNA binding and sequence-selective recognition conferred by the STAT amino-terminal domain.
Xu X; Sun YL; Hoey T
Science; 1996 Aug; 273(5276):794-7. PubMed ID: 8670419
[TBL] [Abstract][Full Text] [Related]
37. Promotion of alpha/beta interferon induction during in vivo viral infection through alpha/beta interferon receptor/STAT1 system-dependent and -independent pathways.
Malmgaard L; Salazar-Mather TP; Lewis CA; Biron CA
J Virol; 2002 May; 76(9):4520-5. PubMed ID: 11932417
[TBL] [Abstract][Full Text] [Related]
38. Expression of interferon alfa signaling components in human alcoholic liver disease.
Nguyen VA; Gao B
Hepatology; 2002 Feb; 35(2):425-32. PubMed ID: 11826419
[TBL] [Abstract][Full Text] [Related]
39. The neutralization of type I IFN biologic actions by anti-IFNAR-2 monoclonal antibodies is not entirely due to inhibition of Jak-Stat tyrosine phosphorylation.
Novick D; Nabioullin RR; Ragsdale W; McKenna S; Weiser W; Garone L; Burkins C; Kim SH; Rubinstein M; Tepper MA; Arulanandam AR
J Interferon Cytokine Res; 2000 Nov; 20(11):971-82. PubMed ID: 11096454
[TBL] [Abstract][Full Text] [Related]
40. Functional significance of globotriaosyl ceramide in interferon-alpha(2)/type 1 interferon receptor-mediated antiviral activity.
Khine AA; Lingwood CA
J Cell Physiol; 2000 Jan; 182(1):97-108. PubMed ID: 10567921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
